FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2060391315> ?p ?o ?g. }

• W2060391315 endingPage "1072" @default.
• W2060391315 startingPage "1066" @default.
• W2060391315 abstract "Our goal was to report our institutional experience with recombinant factor VIIa for the treatment and/or prevention of bleeding in nonhemophiliac children.This was a retrospective case series in a tertiary pediatric referral hospital.During 1999-2006, 135 patients received recombinant factor VIIa for off-label use. The median number of doses was 2; the median dose was 88 mug/kg. The most common diagnoses among patients receiving recombinant factor VIIa were disseminated intravascular coagulation/sepsis (28), surgical bleeding (19), procedural prophylaxis (16), and trauma (15). The median volume of blood products administered 24 hours before recombinant factor VIIa treatment was 29.7 vs 11.7 mL/kg 24 hours after treatment. Only 1 high-risk patient had significant bleeding after receiving prophylactic recombinant factor VIIa before an invasive procedure. Nonsurvivors had significantly increased incidence of multiple organ dysfunction syndrome (75%) compared with survivors (23%). The largest group of patients (n = 28) received recombinant factor VIIa for bleeding and/or coagulopathy because of disseminated intravascular coagulation; the mortality in this group was 26 (93%) of 28. Eleven patients received multiple doses of recombinant factor VIIa to treat bleeding complications after hematopoietic stem cell transplant, without improvement in blood use. Mortality in medical patients was 58% vs 16% in surgical patients. Three patients had significant thrombotic adverse events after receiving recombinant factor VIIa, resulting in 2 deaths and 1 leg amputation.Off-label use of recombinant factor VIIa significantly decreases blood-product administration; surgical patients had control of life-threatening bleeding with low associated mortality. Prophylactic recombinant factor VIIa may be effective in preventing bleeding if given before invasive procedures in children at high risk. Prolonged use of recombinant factor VIIa for bleeding complications after hematopoietic stem cell transplant is not effective in preventing packed red blood cell transfusion. Presence of disseminated intravascular coagulation and mulitorgan dysfunction syndrome may help predict futility of recombinant factor VIIa treatment. Off-label use of recombinant factor VIIa is associated with thromboembolic events in children." @default.
• W2060391315 created "2016-06-24" @default.
• W2060391315 creator A5015066501 @default.
• W2060391315 creator A5036904109 @default.
• W2060391315 creator A5053398722 @default.
• W2060391315 creator A5068629690 @default.
• W2060391315 creator A5082239368 @default.
• W2060391315 creator A5089742002 @default.
• W2060391315 date "2009-03-01" @default.
• W2060391315 modified "2023-09-27" @default.
• W2060391315 title "Pediatric Off-label Use of Recombinant Factor VIIa" @default.
• W2060391315 cites W1518801222 @default.
• W2060391315 cites W1573466087 @default.
• W2060391315 cites W1965780249 @default.
• W2060391315 cites W1967499351 @default.
• W2060391315 cites W1969483730 @default.
• W2060391315 cites W1973477505 @default.
• W2060391315 cites W1975865024 @default.
• W2060391315 cites W1980229644 @default.
• W2060391315 cites W1989016864 @default.
• W2060391315 cites W1995491984 @default.
• W2060391315 cites W2001409489 @default.
• W2060391315 cites W2017757660 @default.
• W2060391315 cites W2033294601 @default.
• W2060391315 cites W2043800309 @default.
• W2060391315 cites W2044129244 @default.
• W2060391315 cites W2054077555 @default.
• W2060391315 cites W2057739806 @default.
• W2060391315 cites W2062240022 @default.
• W2060391315 cites W2066005073 @default.
• W2060391315 cites W2074002677 @default.
• W2060391315 cites W2075429091 @default.
• W2060391315 cites W2076590961 @default.
• W2060391315 cites W2078746591 @default.
• W2060391315 cites W2079275181 @default.
• W2060391315 cites W2083042961 @default.
• W2060391315 cites W2087097664 @default.
• W2060391315 cites W2094457286 @default.
• W2060391315 cites W2094751056 @default.
• W2060391315 cites W2105468396 @default.
• W2060391315 cites W2120269019 @default.
• W2060391315 cites W2127079299 @default.
• W2060391315 cites W2139770696 @default.
• W2060391315 cites W2140699529 @default.
• W2060391315 cites W2158656134 @default.
• W2060391315 cites W2162759184 @default.
• W2060391315 cites W2164107296 @default.
• W2060391315 cites W2165755420 @default.
• W2060391315 cites W269637259 @default.
• W2060391315 cites W4238103798 @default.
• W2060391315 doi "https://doi.org/10.1542/peds.2008-1685" @default.
• W2060391315 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19255041" @default.
• W2060391315 hasPublicationYear "2009" @default.
• W2060391315 type Work @default.
• W2060391315 sameAs 2060391315 @default.
• W2060391315 citedByCount "45" @default.
• W2060391315 countsByYear W20603913152012 @default.
• W2060391315 countsByYear W20603913152013 @default.
• W2060391315 countsByYear W20603913152014 @default.
• W2060391315 countsByYear W20603913152015 @default.
• W2060391315 countsByYear W20603913152016 @default.
• W2060391315 countsByYear W20603913152017 @default.
• W2060391315 countsByYear W20603913152018 @default.
• W2060391315 countsByYear W20603913152019 @default.
• W2060391315 countsByYear W20603913152020 @default.
• W2060391315 countsByYear W20603913152021 @default.
• W2060391315 crossrefType "journal-article" @default.
• W2060391315 hasAuthorship W2060391315A5015066501 @default.
• W2060391315 hasAuthorship W2060391315A5036904109 @default.
• W2060391315 hasAuthorship W2060391315A5053398722 @default.
• W2060391315 hasAuthorship W2060391315A5068629690 @default.
• W2060391315 hasAuthorship W2060391315A5082239368 @default.
• W2060391315 hasAuthorship W2060391315A5089742002 @default.
• W2060391315 hasConcept C126322002 @default.
• W2060391315 hasConcept C141071460 @default.
• W2060391315 hasConcept C197934379 @default.
• W2060391315 hasConcept C2777396833 @default.
• W2060391315 hasConcept C2778382381 @default.
• W2060391315 hasConcept C2778961111 @default.
• W2060391315 hasConcept C2779936836 @default.
• W2060391315 hasConcept C2780930249 @default.
• W2060391315 hasConcept C42219234 @default.
• W2060391315 hasConcept C71924100 @default.
• W2060391315 hasConceptScore W2060391315C126322002 @default.
• W2060391315 hasConceptScore W2060391315C141071460 @default.
• W2060391315 hasConceptScore W2060391315C197934379 @default.
• W2060391315 hasConceptScore W2060391315C2777396833 @default.
• W2060391315 hasConceptScore W2060391315C2778382381 @default.
• W2060391315 hasConceptScore W2060391315C2778961111 @default.
• W2060391315 hasConceptScore W2060391315C2779936836 @default.
• W2060391315 hasConceptScore W2060391315C2780930249 @default.
• W2060391315 hasConceptScore W2060391315C42219234 @default.
• W2060391315 hasConceptScore W2060391315C71924100 @default.
• W2060391315 hasIssue "3" @default.
• W2060391315 hasLocation W20603913151 @default.
• W2060391315 hasLocation W20603913152 @default.
• W2060391315 hasOpenAccess W2060391315 @default.
• W2060391315 hasPrimaryLocation W20603913151 @default.

• next